Skip to content

COMPARISON BETWEEN TWO DIFFERENT DOSES (300MG AND 600MG) OF THE DRUG GABAPENTIN TO ASSESS POST OPERATIVE PAIN TOLERANCE OF PATIENTS UNDERGEOING LOWER LIMB SURGERIES UNDER SPINAL ANAESTHESIA

COMPARISON OF TWO DIFFERENT DOSES OF ORAL GABAPENTIN FOR POST OPERATIVE ANALGESIA IN LOWER LIMB SURGERY UNDER SPINAL ANAESTHESIA

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017145
Enrollment
40
Registered
2019-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: BUPIVACAINE (HEAVY): INTRATHECAL DOSE- 0.5% HEAVY 3.5 ML DRUG TO BE GIVEN INTRATHECALLY WITHOUT ADDITIVES Control Intervention1: GABAPENTIN: ORAL DOSE- 300 MG AND 600 MG DRUG TO BE GIVE

Sponsors

MGM MEDICAL COLLEGE
Lead Sponsor
MGM MEDICAL COLLEGE
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: BOTH MALE AND FEMALE PATIENTS OF AGE GROUP 18-65 YRS RECEIVING SPINAL ANAESTHESIA FOR ELECTIVE LOWER LIMB SURGERIES UNDER ASA GRADE 1 AND 2

Exclusion criteria

Exclusion criteria: 1. PATIENTS WITH ALLERGY TO GABAPENTIN 2. PATIENTS SUFFERING FROM EPILEPSY, LIVER AND RENAL DISEASE, ANY CHRONIC PAIN SYNDROMES, PSYCHIATRIC ILLNESS 3. PATIENTS REQUIRING SURGICAL DURATION MORE THAN 3 HOURS

Design outcomes

Primary

MeasureTime frame
COMPARE TOTAL DURATION OF ANALGESIA AND TOTAL NUMBER OF ANALGESICS REQUIRED IN THE FIRST 24 HOURS AFTER SURGERYTimepoint: 24 HOURS

Secondary

MeasureTime frame
COMPARE SIDE EFFECTS OF THE TWO DOSES OF GABAPENTIN IF ANYTimepoint: 24 HOURS

Countries

India

Contacts

Public ContactMITALEE H PAREEK

MGM MEDICAL COLLEGE AND HOSPITAL

kppnayak@yahoo.com9422209729

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026